COMPARATIVE EFFICACY OF BIMEKIZUMAB FOR THE TREATMENT OF MODERATE TO SEVERE PLAQUE PSORIASIS: A NETWORK META-ANALYSIS

被引：0
|
作者：
Armstrong, A. [1 ]
Reich, K. [2 ]
Warren, R. B. [3 ]
Taieb, V [4 ]
Fahrbach, K. [5 ]
Kazmierska, P. [6 ]
Betts, M. [5 ]
Neupane, B. [5 ]
Kiri, S. [4 ]
Gordon, K. [7 ]
机构：
[1] Keck Sch Med USC, Dermatol, Los Angeles, CA USA
[2] Univ Med Ctr Hamburg Eppendorf, Inst Hlth Serv Res Dermatol & Nursing, Ctr Translat Res Inflammatory Skin Dis, Hamburg, Germany
[3] Univ Manchester, Salford Royal NHS Fdn Trust, Dermatol Ctr, Manchester NIHR Biomed Res Ctr, Manchester, Lancs, England
[4] UCB Pharma, Slough, Berks, England
[5] Evidera, Waltham, MA USA
[6] Evidera, London, Lon, England
[7] Med Coll Wisconsin, Milwaukee, MA USA
来源：
VALUE IN HEALTH | 2021年 / 24卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PBI3
引用
收藏
页码：S14 / S14
页数：1
相关论文
共 50 条
  • [31] Efficacy and safety of guselkumab for the treatment of patients with moderate-to-severe plaque psoriasis: A meta-analysis of randomized clinical trials
    Tao, Xing-Bao
    Huang, Yin-Qiu
    Zhou, Yi-Hong
    Zhang, Lv-Lang
    Chen, Yao-Kai
    [J]. TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2020, 19 (02) : 433 - 440
  • [32] Efficacy of several biological therapies for treating moderate to severe psoriasis: A network meta-analysis
    Geng, Wenjun
    Zhao, Jianhua
    Fu, Jixing
    Zhang, Huamin
    Qiao, Shaohua
    [J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 16 (06) : 5085 - 5095
  • [33] TARGETED IMMUNOMODULATORS FOR THE TREATMENT OF MODERATE-TO-SEVERE PLAQUE PSORIASIS: A NETWORK META-ANALYSIS COMPARING BINOMIAL AND MULTINOMIAL APPROACHES
    Fahim, S. M.
    Wright, A.
    Nikitin, D.
    McKenna, A.
    Agboola, F.
    [J]. VALUE IN HEALTH, 2024, 27 (06) : S279 - S279
  • [34] Efficacy and safety of apremilast monotherapy in moderate-to-severe plaque psoriasis: A systematic review and meta-analysis
    Aljefri, Yara E.
    Ghaddaf, Abdullah A.
    Alkhunani, Tala A.
    Alkhamisi, Taif A.
    Alahmadi, Rana A.
    Alamri, Awadh M.
    Alraddadi, Ali A.
    [J]. DERMATOLOGIC THERAPY, 2022, 35 (07)
  • [35] COMPARATIVE EFFECTIVENESS OF SELECTIVE ANTI-IL-23 AGENTS FOR THE TREATMENT OF MODERATE-TO-SEVERE PLAQUE PSORIASIS: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
    Fazioli, K.
    Agboola, F. O.
    Ellis, A. G.
    Segel, C.
    Ollendorf, D. A.
    Banken, R.
    Pearson, S.
    [J]. VALUE IN HEALTH, 2019, 22 : S52 - S53
  • [36] Meta-analysis of the Efficacy and Safety of Secukinumab for the Treatment of Plaque Psoriasis
    Ryoo, Ju Yeon
    Yang, Hye-Jin
    Ji, Eunhee
    Yoo, Bong Kyu
    [J]. ANNALS OF PHARMACOTHERAPY, 2016, 50 (05) : 341 - 351
  • [37] META-ANALYSIS OF BIOLOGIC THERAPIES FOR THE TREATMENT OF MODERATE TO SEVERE PSORIASIS
    Hawkins, N. S.
    Huntley, A.
    Eaton, J.
    [J]. VALUE IN HEALTH, 2009, 12 (03) : A74 - A75
  • [38] BIMEKIZUMAB EFFICACY IN MODERATE TO SEVERE PLAQUE PSORIASIS: IMPROVEMENTS IN FATIGUE OBSERVED IN TWO PHASE 3 STUDIES
    Gottlieb, Alice B.
    Augustin, Matthias
    Lambert, Jo
    Pinter, Andreas
    Savage, Laura J.
    Tsai, Tsen-Fang
    Foley, Peter
    Paul, Carle
    Warham, Rhys
    Lambert, Jeremy
    Wiegratz, Susanne
    Stahle, Mona
    [J]. ACTA DERMATO-VENEREOLOGICA, 2024, 104
  • [39] A network meta-analysis for the comparison of efficacy and safety of interleukin (IL)-23 targeted drugs in the treatment of moderate to severe psoriasis
    Shi, Jianzhen
    Xu, Jianru
    Chen, Yanmei
    [J]. DERMATOLOGIC THERAPY, 2020, 33 (04)
  • [40] Comparative safety and benefit-risk profile of biologics and oral treatment for moderate-to-severe plaque psoriasis: A network meta-analysis of clinical trial data
    Shear, Neil H.
    Betts, Keith A.
    Soliman, Ahmed M.
    Joshi, Avani
    Wang, Yan
    Zhao, Jing
    Gisondi, Paolo
    Sinvhal, Ranjeeta
    Armstrong, April W.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : 572 - 581
12345